The Toll-like receptor 1/2 ligand Pam3Cys inhibits memory impairment after traumatic brain injury in male and female rats Authors: Mahboobeh Kamrani Mehni, Mohammad Reza Sadeghi, Leila Hasanzadeh, Morteza Zendehdel, Hamid Gholami Pourbadie, Maryam Hooshmand, Mohammad Sayyah Published: 2026 ABSTRACT Amnesia is common after traumatic brain injury (TBI). Toll-like receptor 1/2 agonist, tri-palmitoyl-S-glyceryl-cysteine (Pam3Cys), prevents TBI neuroinflammation. We investigated Pam3Cys potential to ameliorate TBI amnesia, and discerned the effect between male and female. Male and female adult rats were trained in the Morris water maze (n = 160) and shuttle box (n = 80). Then, animals received mild TBI by controlled cortical impact. Twenty min after TBI, Pam3Cys was injected by intra-cerebroventricular route. Spatial memory was assessed 7 and 28 days whereas avoidance memory was evaluated 2 and 6 days after TBI. Brain damage was evaluated by TTC and Nissl staining. Rats effectively learned, with no sex difference, spatial and avoidance tasks by progressive decrease in latency and distance to platform, and avoiding shock chamber during training. One week after acquisition, memory retrieval was disrupted in naïve female rats which traveled 22% more than males to reach platform position (P < 0.01). At four weeks, sham-operated female rats spent 26% less time than males in platform position (P < 0.01). TBI significantly disrupted both spatial and avoidance memories at all measured times. Spatial memory of females showed greater impairment than males at four weeks after TBI (40% less presence in platform position, P < 0.01). No sex difference existed in avoidance memory under control or TBI. Pam3Cys reduced TBI-induced latency increase in both sexes at one week (P < 0.05, P < 0.00001), but at four weeks, only in males (P < 0.05). It also mitigated reduced presence in target quadrant in both sexes at one week (P < 0.05), and in females at four weeks (P < 0.01). Pam3Cys prevented all rats at two days, and 60% of rats at 6 days after TBI, from entering the shock chamber (P < 0.01, P < 0.001 compared to TBI group) with no sex difference. Pam3Cys reduced TBI-induced cortical damage (70% decrease, P < 0.001) and neuronal death (75% decrease, P < 0.001) in the hippocampus. In short periods after mild TBI, impairment of spatial memory and Pam3Cys preventive effect are identical in male and female rats. However, at long-term periods, both effects are prominent in female rats. Modulation of TBI neuroinflammation seems to involve in Pam3Cys effects. Introduction Traumatic brain injury (TBI), caused by external forces such as impact or blast waves, is a major global health concern with an estimated annual incidence of 1% across all severities. Mild TBI accounts for approximately 0.74% of cases, while severe TBI constitutes about 0.073%1. A predominant and debilitating consequence of TBI is cognitive deficit2, which can persist for years or even a lifetime, severely impacting quality of life3. Post-traumatic amnesia (PTA) is a common sequela of moderate to severe TBI, characterized by confusion, disorientation, and both retrograde and anterograde amnesia. Retrograde amnesia involves the loss of memories acquired before the injury, whereas anterograde amnesia is the impaired ability to form new memories. While both types are common indicators of TBI severity4, deficits in autobiographical and anterograde memory are particularly prominent5. Animal studies have been instrumental in modeling these aspects of human PTA, revealing that anterograde impairments often stem from disrupted information processing, while retrograde impairments involve a failure in memory retrieval or consolidation6. Neuroinflammation is a cornerstone of TBI pathogenesis, with Toll-like receptors (TLRs) playing a central role. Expressed on microglia, astrocytes, and neurons, TLRs activate innate immune and inflammatory cascades. Although aberrant TLR signaling contributes to various pathologies, activation of TLRs immediately before or after an insult can paradoxically promote an anti-inflammatory state. This is achieved through the downregulation of pro-inflammatory factors and the production of anti-inflammatory mediators, ultimately leading to neuroprotection7–11. The weak TLR1/2 agonist Pam3Cys emerges as a promising prophylactic and therapeutic candidate for TBI sequelae. It has an established safety profile in humans due to its extensive use as a vaccine adjuvant12. Preclinical studies show that Pam3Cys prevents TBI-induced epileptogenesis8,9 and inhibits β-amyloid-induced neuroinflammation and memory deficits by modulating cytokine secretion13. This neuroprotection is attributed to its ability to steer TLR signaling toward an anti-inflammatory pathway8,9,13. While anterograde memory is frequently assessed in TBI research, both pre-clinically and clinically14–18, the impairment of retrograde memory has received comparatively less systematic investigation5,19–21. The deficit in spatial reference memory, which impairs navigation, is a prevalent issue after TBI. Furthermore, the preservation of avoidance memories is crucial for survival. In this study, we investigated the effects of TBI on retrograde spatial reference and passive avoidance memory using the Morris water maze and shuttle box tests. We evaluated efficacy of post-TBI Pam3Cys treatment in mitigating this amnesia. Male and female rats were trained on these tasks, subjected to TBI, and then treated with Pam3Cys. Memory retrieval was tested at short-term (2, 6, and 7 days) and long-term (4 weeks) intervals. The extent of cortical damage and neuronal survival in the hippocampus, a key region for learning and memory, was also assessed. Results Successful acquisition of spatial learning and memory during training The five-day spatial learning trials demonstrated a notable enhancement of the rats’ performance (Fig. 1). The time spent to find the hidden platform was progressively reduced (Fig. 1A, P < 0.0001), indicating effective acquisition of spatial learning and memory. Using two-way ANOVA and Tukey multiple comparisons test revealed a significant difference in the time factor [F (2.78, 219.9) = 504.3, P < 0.0001], but not in the sex factor [F (1, 79) = 0.05, P = 0.81], and in the interaction of time and sex factors [F (3.03, 239.7) = 1.35, P = 0.25]. Fig. 1Daily assessment of spatial learning in rats using the Morris water maze. (A) Latency to find the hidden platform. (B) Distance traveled to reach the hidden platform. (C) Swimming speed. Data are presented as mean ± SD. Data distribution passed the normality test in all experimental groups (P > 0.1 for both males and females). The results indicate progressive improvement in learning, as evidenced by reductions in both the time taken and the distance traveled to reach the platform.****: P < 0.0001 compared to the first day of learning. Daily assessment of spatial learning in rats using the Morris water maze. (A) Latency to find the hidden platform. (B) Distance traveled to reach the hidden platform. (C) Swimming speed. Data are presented as mean ± SD. Data distribution passed the normality test in all experimental groups (P > 0.1 for both males and females). The results indicate progressive improvement in learning, as evidenced by reductions in both the time taken and the distance traveled to reach the platform.****: P < 0.0001 compared to the first day of learning. The distance traveled to find the hidden platform also progressively decreased (Fig. 1B, P < 0.0001). Two-way ANOVA revealed a significant difference in the time factor [F (4, 316) = 681.6, P < 0.0001], but not in the sex factor [F (1, 79) = 0.069, P = 0.79], and in the interaction of time and sex factors [F (4, 316) = 0.68, P = 0. 6]. The swimming velocity followed a similar decreasing trend in the assessment period (Fig. 1C). Two-way ANOVA showed a significant difference in the time factor [F (4, 316) = 5.57, P < 0.001], but not in the sex factor [F (1, 79) = 0.017, P = 0.89], and in the interaction of time and sex factors [F (4, 266) = 0.028, P = 0.99]. Pam3Cys inhibited the memory impairment observed one week after TBI Latency to reach the platform position No significant difference was found between control, Sham + PBS, and Sham+Pam3Cys groups in both sexes (Fig. 2A). Both male and female rats with TBI showed a significant increase in the latency to reach the platform position, (P < 0.001, and P < 0.0001, compared with respective Sham + PBS groups). Pam3Cys attenuated the TBI-induced increase in latency in both sexes, restoring performance close to sham levels. The difference between TBI + PBS and TBI+Pam3Cys groups was significant in male (P < 0.05), and female (P < 0.0001) rats. Fig. 2Influence of traumatic brain injury and Pam3Cys on spatial memory in rats one week after treatment. (A) Latency to first enter the platform location. (B) Distance traveled to reach the platform location. (C) Time spent in the platform location. Data are presented as mean ± SEM. Data distribution passed the normality test in all experimental groups (P > 0.1 for both males and females).*: P < 0.05, **: P < 0.01, ***: P < 0.001, and ****: P < 0.0001 compared to the corresponding Sham + PBS group. #P < 0.05, # #P < 0.01, # # #: P < 0.001, and # # # #: P < 0.0001 compared to the corresponding Trauma + PBS group. ++: P < 0.01. Influence of traumatic brain injury and Pam3Cys on spatial memory in rats one week after treatment. (A) Latency to first enter the platform location. (B) Distance traveled to reach the platform location. (C) Time spent in the platform location. Data are presented as mean ± SEM. Data distribution passed the normality test in all experimental groups (P > 0.1 for both males and females).*: P < 0.05, **: P < 0.01, ***: P < 0.001, and ****: P < 0.0001 compared to the corresponding Sham + PBS group. #P < 0.05, # #P < 0.01, # # #: P < 0.001, and # # # #: P < 0.0001 compared to the corresponding Trauma + PBS group. ++: P < 0.01. Two-way ANOVA disclosed a significant difference in the treatment factor [F (4, 28) = 55.36, P < 0.0001], but not in the sex factor [F (1, 7) = 0.16, P = 0.69], and in the interaction of sex and treatment factors [F (4, 25) = 2.342, P = 0.0825]. Distance traveled to reach the platform position In both male and female rats, no significant difference was found between control, Sham + PBS, and Sham+Pam3Cys groups (Fig. 2B). However, naïve female rats traveled more distance than naïve male rats to reach the platform position (P < 0.01). Both male and female rats with TBI traveled more distance than the respective Sham + PBS groups (P < 0.001) to reach the platform position. There was a significant difference in the treatment factor [F (4, 70) = 28.12, P < 0.0001], the sex factor [F (1, 70) = 8.84, P < 0.01], and the interaction [F (4, 70) = 3.455, P < 0.05]. Pam3Cys treatment preserved the traveled distance of male and female rats with TBI to the level of the respective Sham + PBS groups. The difference between TBI + PBS and TBI+Pam3Cys groups was significant in male (P < 0.01), and female (P < 0.001) rats. Duration spent in the platform position In both sexes, no significant difference was found between control, Sham + PBS, and Sham+Pam3Cys groups (Fig. 2C). Both male and female rats with TBI spent less time in the platform position compared with the respective Sham + PBS groups (P < 0.01, and P < 0.05, respectively). Pam3Cys significantly increased the time spent around the platform position in both male and female rats with TBI (P < 0.05, TBI+Pam3Cys compared to TBI + PBS group). There was a significant difference in the treatment factor [F (1.95, 15.66) = 26.54, P < 0.0001], and the sex factor [F (1.0, 8.0) = 20.45, P < 0.01], but not the interaction [F (2.93, 14.67) = 3.08, P = 0.06]. Pam3Cys inhibited the memory impairment observed four weeks after TBI Latency to reach the platform position In both sexes, no significant difference was found between control, Sham + PBS, and Sham+Pam3cys groups in the latency to reach the platform position (Fig. 3A). Both male and female rats with TBI showed a significant increase in the latency to reach the platform position (P < 0.05, compared with the respective Sham + PBS groups). Pam3Cys inhibited the TBI-induced increase in latency in male but not female rats. The difference between TBI + PBS and TBI+Pam3Cys groups was significant only in male rats (P < 0.05). Fig. 3Influence of traumatic brain injury and Pam3Cys on spatial memory in rats four weeks after treatment. (A) Latency to first enter the platform location. (B) Distance traveled to reach the platform location. (C) Time spent in the platform location. Data are presented as mean ± SEM. Data distribution passed the normality test in all experimental groups (P > 0.1 for both males and females).*: P < 0.05, and **: P < 0.01, compared to the corresponding Sham + PBS group. #: P < 0.05, and # #: P < 0.01 compared to the corresponding Trauma + PBS group. $: P < 0.001 compared to the female control group. +: P < 0.05, and ++: P < 0.01. Influence of traumatic brain injury and Pam3Cys on spatial memory in rats four weeks after treatment. (A) Latency to first enter the platform location. (B) Distance traveled to reach the platform location. (C) Time spent in the platform location. Data are presented as mean ± SEM. Data distribution passed the normality test in all experimental groups (P > 0.1 for both males and females).*: P < 0.05, and **: P < 0.01, compared to the corresponding Sham + PBS group. #: P < 0.05, and # #: P < 0.01 compared to the corresponding Trauma + PBS group. $: P < 0.001 compared to the female control group. +: P < 0.05, and ++: P < 0.01. Two-way ANOVA revealed a significant difference in the treatment factor [F (2.68, 47.62) = 33.77, P < 0.0001], but not in the sex factor [F (1, 71) = 0.69, P > 0.05], and in the interaction of sex and treatment factors [F (2.039, 36.18) = 0.15, P > 0.05]. Distance traveled to the platform position In male rats, no significant difference was found between control, Sham + PBS, and Sham+Pam3Cys groups (Fig. 3B). However, a significant difference was found between control, and Sham + PBS groups in female rats (P < 0.001). There was a significant difference in the treatment factor [F (2.85, 22.86) = 34.88, P < 0.0001], the sex factor [F (1, 8) = 7.42, P < 0.05], and the interaction [F (2.48, 16.16) = 6.39, P < 0.01]. Both male and female rats with TBI traveled a greater distance than the respective Sham + PBS groups (P < 0.01) to reach the platform position. Pam3Cys treatment kept the traveled distance of male and female rats with TBI to the level of the respective Sham + PBS groups. The difference between TBI + PBS and TBI+Pam3Cys groups was significant in both male and female rats (P < 0.01). No significant difference was found between male and female experimental groups in the distance traveled. Duration spent in the platform position No significant difference was found between control, Sham + PBS, and Sham+Pam3cys groups of both sexes (Fig. 3C). Both male and female rats with TBI spent less time in the platform position compared with the respective Sham + PBS groups (P < 0.01, and P < 0.05, respectively). Pam3Cys significantly increased the time spent around the platform position only in female rats with TBI (P < 0.01 compared to the TBI + PBS group). Male rats of Sham, Sham+Pam3Cys, and TBI + PBS groups spent significantly more time around the platform position compared with the female rats of the same groups (P < 0.01, P < 0.05, and P < 0.01, respectively). There was a significant difference in the treatment factor [F (1.89, 15.13) = 38.80, P < 0.0001], the sex factor [F (1.0, 8.0) = 19.37, P < 0.01], and the interaction [F (2.12, 11.17) = 4.74, P < 0.05]. TBI did not affect the integrity of motor and visual functions No abnormal walking and motor behavior was detected in the animals 2–7 days after injury. The visible test showed no difference between the experimental groups in either the latency to reach the platform or the swimming speed (Fig. 4A and B). All rats successfully located the visible platform. Fig. 4Visual–motor function of rats 8 days after traumatic brain injury and Pam3Cys injection. (A) Latency to find the visible platform. (B) Swimming speed of the animals. No significant differences were observed among the groups. Visual–motor function of rats 8 days after traumatic brain injury and Pam3Cys injection. (A) Latency to find the visible platform. (B) Swimming speed of the animals. No significant differences were observed among the groups. No significant difference was detected between male and female rats in the visual and motor abilities. Pam3Cys hindered the TBI-induced deficiency of passive avoidance memory The number of animals with the preserved passive avoidance memory was significantly decreased 2 and 6 days after the retention phase (day 0) in naïve (control) and sham groups of both sexes (Fig. 5). This decline was not significantly different between male and female rats. Pam3Cys did not significantly affect the memory of the sham-operated rats at either 2 or 6 days after injection. TBI impaired the memory of both male and female rats at both 2 and 6 days after TBI (P < 0.05 and P < 0.01, compared with the respective sham groups). This memory impairment was prevented by Pam3Cys at both 2 (P < 0.001) and 6 (P < 0.01) days post-TBI periods. No significant difference was detected between male and female rats in the destructive effect of TBI and the improving effect of Pam3Cys on the passive avoidance memory. Fig. 5Effect of traumatic brain injury and Pam3Cys on passive avoidance memory in rats. Data are presented as the percentage of rats with preserved avoidance memory. **: P < 0.01, ***: P < 0.001, and ****: P < 0.0001 compared to day 0 (the day of the retention test). ^: P < 0.05, and ^^: P < 0.01, compared to the corresponding sham group. # #: P < 0.01, # # #: P < 0.001, and # # # #: P < 0.0001 compared to the corresponding TBI group. Day − 1 is the learning day. Effect of traumatic brain injury and Pam3Cys on passive avoidance memory in rats. Data are presented as the percentage of rats with preserved avoidance memory. **: P < 0.01, ***: P < 0.001, and ****: P < 0.0001 compared to day 0 (the day of the retention test). ^: P < 0.05, and ^^: P < 0.01, compared to the corresponding sham group. # #: P < 0.01, # # #: P < 0.001, and # # # #: P < 0.0001 compared to the corresponding TBI group. Day − 1 is the learning day. Pam3Cys reduces TBI-induced damage A deformation depth of 2 ± 0.02 mm was detected in the cerebral cortex at both 7 and 28 days after TBI (Fig. 6A and B). This finding indicates the presence of a mild-to-moderate TBI. The size of damage in male rats was significantly decreased after administration of Pam3Cys at both 7-day and 28-day post-TBI periods (P < 0.0001 and P < 0.001, respectively). The size of TBI damage and the effect of Pam3Cys in the female rats were similar to those of male rats, with no significant statistical difference. Therefore, results are not shown. Fig. 6Effect of TBI and Pam3Cys on the size of brain injury at 7 and 28 days after TBI in male rats. (A,B) Data corresponding to 7 and 28 days after TBI, respectively. Values are presented as mean ± SEM. ***: P < 0.001, ****: P < 0.0001. Each square in the checkered background represents 1 mm × 1 mm. The yellow oval indicates the TBI area. No cortical damage was observed in the sham group. Effect of TBI and Pam3Cys on the size of brain injury at 7 and 28 days after TBI in male rats. (A,B) Data corresponding to 7 and 28 days after TBI, respectively. Values are presented as mean ± SEM. ***: P < 0.001, ****: P < 0.0001. Each square in the checkered background represents 1 mm × 1 mm. The yellow oval indicates the TBI area. No cortical damage was observed in the sham group. Pam3Cys reduced cell death in CA1 and CA3 hippocampal regions induced by TBI Figure 7 shows the number of surviving neurons in the hippocampal CA1, CA3, and dentate gyrus 7 and 28 days after TBI. The cells with intact nuclei were quantified in the hippocampal sub-regions. The shrunken neurons in CA1 and CA3 were significantly higher in the TBI + PBS group (P < 0.0001), compared to the Sham + PBS group at both 7 and 28 days after TBI. No significant difference was found between Sham+Pam3Cys and Sham + PBS groups at both 7 and 28 days (P > 0.05). The number of normal neurons in the CA1 and CA3 was significantly higher in TBI rats after treatment with Pam3Cys at both 7 days (F [4, 15] = 78.43, P < 0.0001,) and 28 days (F [4, 15] = 72.27, P < 0.0001) after TBI. No significant change was observed in the number of normal neurons in DG at both periods after TBI. Fig. 7Effect of TBI and Pam3Cys on neuronal loss in the rat hippocampus at 7 and 28 days after TBI. The upper left panel shows a schematic coronal section of the rat brain, adapted from the Paxinos and Watson (2007) rat brain atlas. The lower left panel displays an image of a Nissl-stained brain section highlighting the CA1, CA3, and dentate gyrus (DG) regions. The middle and right panels present higher-magnification images of Nissl-stained sections from the experimental groups, focusing on the CA1, CA3, and DG areas. The histograms show the number of viable neurons in the CA1, CA3, and DG regions across experimental groups. Data are expressed as the mean ± standard error of the mean (SEM) of intact neuron counts in the hemisphere that experienced TBI. Statistical significance is indicated as follows: *: P < 0.05, **: P < 0.01, ***: P < 0.001, ****: P < 0.0001. Scale bar = 100 μm. Effect of TBI and Pam3Cys on neuronal loss in the rat hippocampus at 7 and 28 days after TBI. The upper left panel shows a schematic coronal section of the rat brain, adapted from the Paxinos and Watson (2007) rat brain atlas. The lower left panel displays an image of a Nissl-stained brain section highlighting the CA1, CA3, and dentate gyrus (DG) regions. The middle and right panels present higher-magnification images of Nissl-stained sections from the experimental groups, focusing on the CA1, CA3, and DG areas. The histograms show the number of viable neurons in the CA1, CA3, and DG regions across experimental groups. Data are expressed as the mean ± standard error of the mean (SEM) of intact neuron counts in the hemisphere that experienced TBI. Statistical significance is indicated as follows: *: P < 0.05, **: P < 0.01, ***: P < 0.001, ****: P < 0.0001. Scale bar = 100 μm. Discussion In the present study, we demonstrated that adult male and female rats learned spatial and passive avoidance tasks to a similar extent. However, sex differences emerged in the retrieval phase of both types of memory across short- (2, 6, and 7 days) and long-term (28 days) intervals. Although traumatic brain injury (TBI) impaired memory performance, the overall magnitude of memory impairment, tissue damage, and neuronal loss in the hippocampus did not differ significantly between sexes. Importantly, administration of Pam3Cys improved TBI-induced deficits in memory and tissue integrity in both male and female rats to a similar extent. TBI-induced retrograde memory impairment The controlled cortical impact (CCI) model used in this study provided a reliable experimental paradigm for reproducing localized brain damage and associated neuropathological alterations similar to those seen in clinical cases of head trauma22. Using mild-to-moderate TBI applied to the temporo-parietal cortex, we observed retrograde impairments in both spatial and passive avoidance memories up to 28 days post-injury. These findings are consistent with earlier studies reporting that TBI disrupts spatial memory performance within 10–30 days post-injury23–25. While previous investigations have often focused on anterograde memory deficits following TBI, our approach assessed retrograde memory loss—an aspect more directly relevant to clinical retrograde amnesia observed in patients. Consistent with our previous report26, the present data confirm that both short- and long-term retrograde memory functions are susceptible to mild-to-moderate TBI, suggesting that this model effectively parallels human post-traumatic amnesia. Sex differences in learning and memory retention In naïve animals, males and females showed comparable learning capabilities in both tasks. However, differences emerged in memory retention. Male rats displayed superior retention of spatial memory four weeks after acquisition and performed better in probe trials compared to females. These findings are consistent with prior reports indicating better spatial memory retrieval in males than females27,28, potentially attributable to hormonal fluctuations in estrogen levels during the estrous cycle29. In contrast, no significant sex difference was detected in passive avoidance memory, although female rats exhibited slightly better performance two days after acquisition in all experimental groups. This observation aligns with previous studies suggesting superior passive avoidance performance in females30,31, but contrasts with others reporting male predominance32–34. The variability among studies may reflect methodological differences or hormonal influences on emotional and motivational aspects of avoidance behavior. Effects of TBI and Pam3Cys on memory performance TBI produced marked impairments in both spatial and passive avoidance memory. Interestingly, the detrimental effect of TBI on spatial memory appeared more pronounced in female rats four weeks post-injury. Despite this, Pam3Cys treatment effectively prevented TBI-induced deficits in both sexes. In sham-operated females, Pam3Cys reduced the time spent around the platform, suggesting potential modulatory effects on baseline memory performance. Consistent with previous work, Pam3Cys—a TLR1/2 agonist—has been shown to exert neuroprotective effects in various models of neuroinflammation-based disorders. Pretreatment with Pam3Cys mitigates neurological impairments after TBI8, attenuates learning and memory disturbances in Alzheimer’s models via cytokine modulation13, and confers protection in ischemic brain and cardiac injury models through TLR2- and TLR9-dependent mechanisms35,36. Together, these findings highlight the broad therapeutic potential of TLR1/2 activation in mitigating neuroinflammatory and neurodegenerative outcomes. Neuroprotective effects of Pam3Cys on hippocampal damage Histological analyses revealed significant neuronal loss in the CA1 and CA3 subfields of the hippocampus following TBI, consistent with the established role of the hippocampus in memory and learning processes37,38. Pam3Cys treatment significantly reduced neuronal death and lesion size, indicating a protective effect against TBI-induced neurodegeneration. While TTC staining provided an overview of irreversible brain damage39, Nissl staining further confirmed the neuronal preservation mediated by Pam3Cys. This finding supports our previous work demonstrating that TLR1/2 post-conditioning with Pam3Cys prevents excitotoxicity and neuronal death following TBI9. Mechanisms underlying Pam3Cys-mediated neuroprotection The neuroprotective actions of Pam3Cys appear to be mediated through modulation of the neuroinflammatory response. Previous studies from our group showed that intraventricular administration of Pam3Cys 20 min after TBI suppresses TNF-α overproduction while upregulating the anti-inflammatory cytokine IL-109. This cytokine shift is achieved via microglial reprogramming toward an M2 anti-inflammatory phenotype. The present results further suggest that these anti-inflammatory and microglia-modulating effects underlie the observed improvements in memory performance and neuronal survival. Conclusions and future directions Collectively, our findings provide additional evidence supporting the therapeutic potential of TLR1/2 activation by Pam3Cys in mitigating cognitive and histological consequences of TBI. Pam3Cys effectively prevented retrograde amnesia and hippocampal cell loss in both male and female rats with comparable efficacy. Further studies are warranted to evaluate the translational potential of Pam3Cys across different TBI models, including diffuse and blast-induced injuries, and to elucidate its long-term safety and mechanistic pathways. Limitations of the study This study has several limitations that should be acknowledged. First, the avoidance memory results may have been confounded by motor deficits, as motor function was not specifically assessed following TBI. Second, we did not investigate the underlying mechanisms responsible for the beneficial effects of Pam3Cys on retrograde post-traumatic amnesia (PTA). Mechanistic assessments were limited to histological and behavioral endpoints; molecular studies are needed to determine whether, as suggested by our previous findings9, alterations in microglial polarization contribute to the observed neuroprotective and memory-preserving effects of Pam3Cys. Third, our assessment focused exclusively on gray-matter injury, whereas white-matter damage represents a major pathological feature of TBI. Evaluating the effects of Pam3Cys on axonal integrity and myelination would provide further insight into the cellular mechanisms underlying its protective action against retrograde PTA. Fourth, Pam3Cys was administered via intracerebroventricular injection. Although this route allows for precise central delivery, systemic administration would enhance the translational relevance of our findings to clinical settings. Investigating peripheral delivery routes, such as intravenous or intranasal administration, will be essential for future preclinical development. Fifth, Pam3Cys was administered relatively early, 20 min after TBI. While this treatment window proved effective in rats, the therapeutic efficacy of Pam3Cys across broader post-injury intervals, including several hours after trauma, should be evaluated to establish clinically practical timeframes for intervention. Sixth, the current study demonstrated that moderate TBI induces a retrograde PTA lasting up to four weeks, which was prevented by Pam3Cys. However, depending on injury severity, PTA can persist for longer durations. The effectiveness of Pam3Cys against more prolonged or severe forms of retrograde amnesia remains unknown and warrants further investigation. Seventh, the estrous cycle of female rats was not controlled, which may have contributed to variability in memory performance. Lastly, the study focused on retrograde memory, and anterograde effects remain to be explored. Materials and methods Animals Adult male (250–270 g, 2.5 months old) and female (180–200 g, 2.5 months old) Wistar rats were obtained from the Pasteur Institute of Iran (n = 240). They were housed in groups of four per polypropylene cage, with ad libitum access to food and water, under a 12-hour light/dark cycle (08:00–20:00) at a controlled temperature of 23 ± 1 °C. All animal procedures were approved by the Ethics Committee of the National Institute for Medical Research Development (NIMAD) under authorization code IR.NIMAD.REC.1402.069. All methods were performed in accordance with the relevant guidelines and regulations of NIMAD. The study was conducted in compliance with the ARRIVE guidelines and the European Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. The sample size was calculated based on extrapolation of outcomes from our previous study13. Given the expected effect size of 2.6 (derived from Morris Water Maze data), a type I error of 0.05, a power of 0.8, and an allocation ratio of 1:1, the raw sample size per group was determined to be 7 using free-access software (https://www.statskingdom.com/sample_size_regression.html). Considering a 10% attrition rate (due to possible death after traumatic brain injury), the corrected sample size per group was calculated as 8 (7 / 0.9 = 7.77). Given the presence of 30 experimental groups, a total of 240 rats were used. Assessment of spatial memory The spatial memory of rats was assessed using the Morris water maze according to the procedure outlined in our previous study26. The maze consisted of a cylindrical swimming pool (155 cm in diameter and 50 cm in height) with a black interior wall, filled with tap water to a depth of 25–30 cm. The water temperature was maintained at 21 ± 1 °C. The maze was hypothetically divided into four equal quadrants. A rescue platform (10 cm in diameter and 25 cm in height) was placed in one of the quadrants, approximately 2 cm below the water surface, making it invisible from outside the pool. The maze was located in a room containing various spatial cues visible to the animals while swimming. The setup was monitored with a tracking CCD camera (Panasonic Inc., Japan) positioned 180 cm above the center of the maze. Locomotion tracking was analyzed using EthoVision software (version XT7, Netherlands), an automated video-tracking system for behavioral analysis. Twenty-four hours before training, the animals were allowed to swim in the pool for 60 s without a platform to adapt to the environment. During training (learning or acquisition phase), the platform was submerged in one of the quadrants, and its location remained constant throughout the training. However, the animals were released into the water (facing the wall of the tank) from different starting points. Each rat received four training sessions per day for five consecutive days. Each session consisted of four trials with 10-min inter-trial intervals. In each trial, animals were allowed to swim for up to 60 s to locate the platform. Rats that failed to find the platform within 60 s were gently guided to it and allowed to rest there for 10 s. Successful navigation indicated effective spatial learning. Memory retention was assessed by a spatial probe test. In this test, the platform was removed, and the rats were released into the quadrant opposite to the former platform location for a 1-min exploration period. The latency to the first entry into the target quadrant, the distance traveled to the former platform site, and the time spent in the target quadrant were recorded. One day after the probe test (day 8 after TBI or sham operation), visual and motor functions were evaluated. This test did not require spatial orientation and was performed to assess any motor or visual impairments that might interfere with the animal’s ability to reach the platform. The procedure was identical to the learning phase, except that the platform was placed 1 cm above the water surface in the quadrant opposite to the previous target quadrant. Each animal entered the maze three times, each time from a different quadrant. After finding the platform, the animal was placed on it, and the latency and swimming speed to reach the platform were recorded. Assessment of passive avoidance memory The passive avoidance memory of the animals was evaluated using a shuttle box apparatus according to the procedure described in our previous study26. The apparatus consisted of two chambers—one bright and one dark—each measuring 20 × 20 × 30 cm, separated by a guillotine door (7 × 9 cm). The floor of the chambers was made of stainless-steel grids (2.5 mm in diameter, spaced 1 cm apart). The floor of the dark compartment was connected to an insulated stimulator. On the first day (Day − 1, learning phase), each rat was placed in the bright chamber, and the guillotine door was opened, allowing the animal to explore the apparatus for 60 s. The animal was then returned to its cage. Thirty minutes later, the procedure was repeated as a training session, and a foot shock (50 Hz, 1 mA for 5 s) was delivered once the animal entered the dark chamber. After 20 s, the rat was returned to its cage. Two min later, the procedure was repeated, and acquisition was considered successful if the rat did not enter the dark chamber for 300 s (step-through latency). Twenty-four hours later (Day 0, retention test), the rat was placed in the light chamber, the door was opened, and its behavior was monitored for 300 s. The step-through latency was recorded. Animals that did not enter the dark chamber within 300 s on Day 0 were considered to have acquired avoidance memory. The motor function of the rats was assessed by observing their ability to walk on a flat surface and make contact with the surface using both their palms and soles. Stereotaxic surgery and induction of mild-to-moderate TBI TBI was induced in rats according to a previously established procedure8. The animals were anesthetized by intraperitoneal (i.p.) co-injection of ketamine (100 mg/kg; Alfasan, The Netherlands) and xylazine (10 mg/kg; Alfasan, The Netherlands). After confirming deep anesthesia, the head was secured in a stereotaxic frame. The coordinates of the left lateral ventricle were determined using the Paxinos and Watson atlas40 and marked on the skull surface at AP: − 0.96 and ML: − 1.8. The marked site was drilled using a dental drill under sterile conditions. A 5-mm-diameter burr hole was also made on the right side of the skull, 4 mm posterior and 4 mm lateral to the bregma. The bone was carefully removed, exposing the parietotemporal cortex. TBI was produced through the burr hole using a controlled cortical impact device (AmScience Instruments, USA). The impact was delivered by a pneumatic piston with a 5-mm-diameter tip, at a velocity of 4.5 m/sec for 150 msec. Immediately after TBI, the circular piece of skull was repositioned and secured with dental cement. Intracerebroventricular Injection of Pam3Cys Pam3Cys (Abcam Co., USA; 1 µg/5 µl) was injected into the lateral ventricle (i.c.v.) 20 min after TBI, at the pre-marked site and 3.4 mm below the dura. The injection was performed using a 30-gauge dental needle connected to a 5-µl Hamilton syringe via a polyethylene tube. The dosage was selected based on our previous studies8,9. Pam3Cys was dissolved in sterile phosphate-buffered saline (PBS) at pH 7.5. Following the injection, the skull surface was disinfected with Betadine, and the skin was sutured. The rats were then transferred to a warm environment for recovery. Sham-operated animals underwent the same surgical procedures except that they did not receive CCI. Histology Lesion volume analysis The depth and volume of brain injury following TBI were determined using 2,3,5-triphenyltetrazolium chloride (TTC; Sigma-Aldrich, Austria) staining9. The subjects were euthanized by carbon dioxide asphyxiation, and the brains were rapidly removed and sectioned into 2-mm coronal slices using a rat brain matrix. The slices were immediately immersed in a 2% TTC solution (w/v in 0.9% NaCl) at 37 °C for 10 min. Regions showing no staining were identified as damaged areas. The area of the unstained region and the total area of each section were measured using ImageJ software (version 1.8; National Institutes of Health, USA). These values were multiplied by the section thickness (2 mm) to calculate the corresponding volumes. The total lesion volume was obtained by summing the lesion volumes of all sections. Data are expressed as the mean ratio of total lesion volume to the total volume of the corresponding sections. Nissl staining On days 7 and 28 after TBI, and 3 h after the probe test, rats were deeply anesthetized and perfused transcardially with 4% paraformaldehyde (Merck, Germany) in 0.1 M PBS through the ascending aorta. The brains were collected and post-fixed in 4% paraformaldehyde overnight at 4 °C. The fixed tissues were then dehydrated, vitrified, and embedded in paraffin. Sections of 5 μm thickness were prepared. From the beginning to the end of the injured region, one out of every ten sections was selected for staining. The brain sections were dewaxed, hydrated and rehydrated by ethanol serial dilutions. The sections were then stained with 0.5% cresyl violet (Merck, Germany). The stained sections were dehydrated in 95% ethanol for 5 min, followed by 100% ethanol for 10 min, and cleared in xylene for 10 min before being mounted. Counting neurons in the hippocampus Cell counting was performed by an experimenter blinded to the identity of the sections. Images of the hippocampal CA1, CA3, and dentate gyrus (DG) regions were captured using an optical microscope (Olympus Optical Co. Ltd., Japan) at 40× magnification. Undamaged neurons were identified and counted using Metamorph image analysis software. Experimental design Eighty male and eighty female rats were subjected to a 5-day learning phase in the Morris water maze. The day after completing the learning phase, the animals were randomly divided into ten groups, with eight rats of the same sex in each group. There were two control (naïve) groups: The 7-day control group, in which memory retrieval was assessed seven days after the 5-day learning phase. The 28-day control group, in which memory retrieval was assessed four weeks after the 5-day learning phase. There were two Sham + PBS groups, in which trained rats underwent a sham operation. Twenty min later, they received PBS (i.c.v.), and memory retrieval was assessed either 7 or 28 days thereafter. There were two Sham+Pam3Cys groups, which underwent the same procedure as the Sham + PBS groups, except that Pam3Cys was administered instead of PBS. There were two TBI + PBS groups, which underwent the same procedure as the Sham + PBS groups, except that they were subjected to TBI instead of the sham operation. Finally, there were two TBI+Pam3Cys groups, which underwent the same procedure as the TBI + PBS groups, except that Pam3Cys was administered instead of PBS. After memory evaluation using the Morris water maze probe test, histological assessments were performed, including TTC staining (using four rats from each group) and Nissl staining (using four rats from each group). An additional eighty rats (forty males and forty females) were used for the passive avoidance test. Following consolidation of avoidance memory (Day 0), animals of each sex were randomly divided into five groups (eight rats per group): control, Sham + PBS, Sham+Pam3Cys, TBI + PBS, and TBI+Pam3Cys. The treatment procedures were identical to those described for the spatial memory assessment. Avoidance memory was evaluated 2 and 6 days after the TBI or sham operation. The experimental design and timeline of the study are illustrated in Fig. 8. Fig. 8Study design and experimental timeline. Study design and experimental timeline. Statistical analysis The data were analyzed using GraphPad Prism software version 9.4. The results of avoidance learning and memory are presented as the percentage of rats that learned the task, and were analyzed using Fisher’s exact test. Data on spatial learning and memory, neuronal counts, and lesion volume are expressed as mean ± standard error of the mean (SEM). The normality of these data was evaluated using the Shapiro–Wilk test. Normally distributed data were analyzed using one-way ANOVA followed by Dunnett’s post hoc test. Data for spatial memory were analyzed using two-way ANOVA followed by Tukey’s multiple comparisons test. Statistical significance was set at P < 0.05 for all analyses.